Neoplastic Meningitis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Study of Osimertinib in Patients With a Lung Cancer With Brain or Leptomeningeal Metastases With EGFR Mutation
Conditions: Non Small Cell Lung Cancer Metastatic; Leptomeningeal Metastasis; Brain Metastases; EGFR Activating Mutation Intervention: Drug: Osimertinib Sponsor: Intergroupe Francophone de Cancerologie Thoracique Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 18, 2020 Category: Research Source Type: clinical trials